Altace and Fluid intake reduced - a phase IV clinical study of FDA data

Summary:

Fluid intake reduced is reported as a side effect among people who take Altace (ramipril), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Synthroid, and have Cardiac disorder.

The phase IV clinical study analyzes which people have Fluid intake reduced when taking Altace. It is created by eHealthMe based on reports of 23,086 people who have side effects when taking Altace from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Fluid intake reduced?

Fluid intake reduced is found to be associated with 551 drugs and 624 conditions by eHealthMe. Check the latest studies of Fluid intake reduced.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

23,086 people reported to have side effects when taking Altace.
Among them, 22 people (0.1%) have Fluid intake reduced.

Could Altace cause Fluid intake reduced?

Among these 22 people:

How long have people been on Altace when they have Fluid intake reduced? *

What is the gender of people who have Fluid intake reduced when taking Altace? *

female: 76.19 %
male: 23.81 %

What is the age of people who have Fluid intake reduced when taking Altace? *

What are other drugs people take besides Altace? *

What are other side effects people have besides Fluid intake reduced? *

Dehydration (dryness resulting from the removal of water): 13 people, 59.09%
Acute Kidney Failure: 11 people, 50.00%
Diarrhea: 8 people, 36.36%
Nausea (feeling of having an urge to vomit): 8 people, 36.36%
Blood Creatinine Increased: 7 people, 31.82%
Weakness: 6 people, 27.27%
Nausea And Vomiting: 5 people, 22.73%
Blood Urea Increased: 5 people, 22.73%
Pain: 4 people, 18.18%
Fatigue (feeling of tiredness): 4 people, 18.18%

What are the existing conditions these people have? *

Cardiac Disorder: 3 people, 13.64%
Ventricular Dysfunction (heart dysfunction): 1 person, 4.55%
Type 2 Diabetes: 1 person, 4.55%
Asthma: 1 person, 4.55%
Cancer - Throat Or Larynx: 1 person, 4.55%
Cardiac Failure: 1 person, 4.55%
Cardiac Failure Chronic: 1 person, 4.55%
Chronic Renal Failure (kidney failure): 1 person, 4.55%
Coagulation Factor Deficiency (lack of clotting substance in blood): 1 person, 4.55%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and have Fluid intake reduced?

- Check whether Fluid intake reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Altace:

Altace (23,681 reports)

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid intake reduced:

Fluid intake reduced (551 drugs)

Browse all the conditions that are associated with Fluid intake reduced:

Fluid intake reduced (624 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Altace) and Altace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.